Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
Dr. Bhimireddy holds advanced qualifications including a Doctorate of Philosophy in synthetic organic chemistry from the renowned Indian Institute of Chemical Technology. Subsequently undertaking specialized postdoctoral studies at Harvard University operating under the supervision of Nobel Laureate Professor E.J. Corey, he has amassed over 15 years’ experience across the disparate yet interrelated realms of academia, pharmaceutical industry engagement, and healthcare sector contributions. Dr. Bhimireddy’s diverse portfolio encompasses pivotal research striving in the multifarious domains of drug discovery, antibody-drug conjugation schemata, peptide synthesis methodologies, and assorted small molecular paradigms, with far-reaching import for pharmaceutical and biomedical applications. He has been an author and co-author of over a decade of publications, including highly ranked the Journal of the American Chemical Society (JACS). Additionally, Dr. Bhimireddy holds commercial patents in healthcare and pharmaceutical research, underscoring his innovative contributions to the field.
Dr. Pisipati brings two decades of experience to Auxiliary Biosciences, with special focus on small molecular drug discovery in the field of anti-infectives. Holding a Ph.D. in Medical Microbiology from the University of Manitoba, his hands-on leadership and guidance have driven significant advancement. Notably, his groundbreaking research at Harvard University under the mentorship of Professors Andrew G. Myers, has resulted in publications in prestigious peer-reviewed publications including Nature, Nature Communications, and the Journal of the American Chemical Society. His pioneering work in in-vitro and in-vivo profiling of fully synthetic antibacterial agents has attracted widespread commendation. Dr. Pisipati’s commitment to innovation and collaborative spirit continue enabling therapeutic breakthroughs.
Dr. Manan currently holds a research scientist position at the esteemed Massachusetts Institute of Technology where he participates in close collaboration with distinguished faculty such as Professors Robert S. Langer and Daniel Anderson of Moderna and Crisper Therapeutics renown. Specializing in diverse bioscience applications including mRNA delivery methodologies, gene editing technologies, and complex molecular synthesis, he holds advanced qualification with a Doctorate of Philosophy from North Dakota State University. Impacting work appearing across 12 peer-reviewed journals incorporates contributions to the highly prestigiously ranked Nature Biotechnology and Nature Biomedical Engineering. Additionally, Dr. Manan owns two patents exemplifying his expertise in designing biodegradable lipid constructs for mRNA delivery and CRISPR-Cas9 purposes, continuing to facilitate therapeutic innovations through his research acumen and teamwork proclivities.
With an illustrious 20-year career spanning CRO Business, Discovery Research, and Process Research and Development, Naresh Akavaram's expertise has left an indelible mark on renowned organizations such as Curia Singapore, Sai Life Sciences, Aurigene Life Sciences, Aragen, and BASR Fine Chemicals. Akavaram's profound understanding of the pharmaceutical and life sciences sectors positions him as an invaluable asset to Auxiliary Biosciences.